Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Jonasch

Showing results (241-250 of 271) with videos related to

Pageof 28
Sort By:
Science Translational Medicine|April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapyPavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Urologic Oncology|November 5, 2024
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meetingStephanie A Berg, Salvatore La Rosa, Tian Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research SummitToni K Choueiri, Laurence Albiges, Michael B Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2021
Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
Testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Pageof 28

Showing results (241-250 of 271) with videos related to

Sort By:
Pageof 28
Science Translational Medicine|April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapyPavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Urologic Oncology|November 5, 2024
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meetingStephanie A Berg, Salvatore La Rosa, Tian Zhang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research SummitToni K Choueiri, Laurence Albiges, Michael B Atkins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2020
Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 2021
Correction: Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney CancerSophie J Cowman, Daniel G Fuja, Xian-De Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 16, 2011
Kidney cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 12, 2012
Testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyRobert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Pageof 28